☰

Hildegund Ertl

Affiliations: 
Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Genetics, Medicine and Surgery, Immunology, Virology Biology
Google:
"Hildegund Ertl"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Julie C. Fitzgerald grad student 2004 Penn
Scott E. Hensley grad student 2006 Penn
Shih-Wen ( Lin grad student 2008 Penn
Steven Tuyishime grad student 2013 Penn
Te-Lang ( Wu grad student 2013 Penn
Rachel M. Leskowitz grad student 2014 Penn
Juliana C. Small grad student 2014 Penn

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ertl HCJ. (2023) Circumventing B Cell Responses to Allow for Redosing of Adeno-Associated Virus Vectors. Human Gene Therapy
Afkhami S, D'Agostino MR, Vaseghi-Shanjani M, et al. (2023) Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice. Npj Vaccines. 8: 25
Ertl HCJ. (2023) Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression. Drugs
Hasanpourghadi M, Novikov M, Ambrose R, et al. (2022) Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19. Microbes and Infection. 105082
Ertl HCJ, Currie SL, Luber AD. (2022) Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health. Frontiers in Immunology. 13: 985382
Ertl HCJ. (2022) Immunogenicity and toxicity of AAV gene therapy. Frontiers in Immunology. 13: 975803
Jenkin D, Ritchie AJ, Aboagye J, et al. (2022) Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial. The Lancet. Microbe
Hasanpourghadi M, Novikov M, Ambrose R, et al. (2022) T cell responses to adenoviral vectors expressing the SARS-CoV-2 nucleoprotein. Current Trends in Microbiology. 15: 1-28
Herati RS, Knorr DA, Vella LA, et al. (2022) PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nature Immunology. 23: 1183-1192
Ertl HCJ, Currie SL, Livermore DM. (2022) Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19? Frontiers in Public Health. 10: 929445
See more...